Summary
A polymerase chain reaction (PCR) based assay capable of detecting and differentiating seven strains of equine arteritis virus (EAV) from around the world was developed. The primers for the PCR were chosen from the ORF 6 gene encoding the unglycosylated membrane protein (M). Viral RNA from cell culture fluids infected with each of the seven EAV strains and RNA from the live vaccine, Arvac, was detected by PCR using four sets of primers. The sensitivity of detection was increased from 100 to 1000 times by performing nested PCR enabling the detection of RNA at a level of 0.5–5 PFU. Differentiation among the virus strains and the live vaccine was achieved by cutting the PCR-amplified products from three sets of primers with six restriction endonucleases. Using this procedure it was possible to distinguish among the seven EAV strains used.
Article PDF
Avoid common mistakes on your manuscript.
References
Belák S, Ballagi-Pordány A, Timoney PJ, McCollum WH, Little TV, Hyllseth B, Klingeborn B (1994) Evaluation of a nested PCR assay for the detection of equine arteritis virus infection. Proceedings of the seventh international conference on equine infectious disease, Tokyo, 1994. R&W Publications, Newmarket, pp 33–38
Bürki F (1965) Eigenschaften des Virus der Equinen Arteritis. Pathol Microbiol 28: 939–949
Bürki F (1970) The virology of equine arteritis. Proceedings of the 2nd international conference on equine infectious diseases, Paris 1969. Karger, Basel München New York, pp 125–129
Chirnside ED, Spaan WJM (1990) Reverse transcription and cDNA amplification by the polymerase chain reaction of equine arteritis virus (EAV). J Virol Methods 30: 133–140
Chirnside ED, Wearing CM, Binns MM, Mumford JA (1994) Comparison of M and N gene sequences distinguishes variation amongst equine arteritis virus isolates. J Gen Virol 75: 1491–1497
Conzelmann K-K, Visser N, van Woensel P, Thiel H-J (1993) Molecular characterization of porcine reproductive and respiratory syndrome virus, a member of the arterivirus group. Virology 193: 329–339
den Boon JA, Snijder EJ, Chirnside ED, de Vries AAF, Horzinek MC, Spaan WJM (1991) Equine arteritis virus is not a togavirus but belongs to the coronaviruslike superfamily. J Virol 65: 2910–2920
Doll ER, Bryans JT, McCollum WH, Crowe MEW (1957) Isolation of a filterable agent causing arteritis of horses and abortion by mares. Its differentiation from the equine abortion (influenza) virus. Cornell Vet 47: 3–41
Doll ER, Bryans JT, Wilson JC, McCollum WH (1968) Immunization against equine viral arteritis using modified live virus propagated in cell cultures of rabbit kidney. Cornell Vet 58: 497–524
Fukunaga Y, Matsumura T, Sugiura T, Wada R, Imagawa H, Kanemaru T, Kamada M (1994) Use of the serum neutralisation test for equine viral arteritis with different virus strains. Vet Rec 134: 574–576
Golnik W, Moraillon A, Golnik J (1986) Identification and antigenic comparison of equine arteritis virus: isolated from an outbreak of epidemic abortion of mares. J Vet Med B 33: 413–417
Huntington PJ, Ellis PM, Forman AJ, Timoney PJ (1990) Equine viral arteritis. Aust Vet J 67: 429–431
Kwok S, Kellogg DE, McKinney N, Spasic D, Goda L, Levenson C, Sninsky JJ (1990) Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies. Nucleic Acids Res 18: 999–1005
McCollum WH (1969) Development of a modified virus strain and vaccine for equine viral arteritis. J Am Vet Med Assoc 155: 318–322
McCollum WH, Swerczek TW (1978) Studies of an epizootic of equine viral arteritis in racehorses. J Equine Med Surg 2: 293–299
Meng X-J, Paul PS, Halbur PG (1994) Molecular cloning and nucleotide sequencing of the 3′-terminal genomic RNA of the porcine reproductive and respiratory syndrome virus. J Gen Virol 75: 1975–1801
Meulenberg JJM, Hulst MM, de Meijer EJ, Moonen PLJM, den Besten A, de Kluyver EP, Wensvoort G, Moormann RJM (1993) Lelystad virus, the causative agent of porcine epidemic abortion and respiratory syndrome (PEARS), is related to LDV and EAV. Virology 192: 62–72
Mumford JA (1985) Preparing for equine arteritis. Equine Vet J 17: 6–11
Murphy TW, Timoney PJ, McCollum WH (1988) Analysis of genetic variation among strains of equine arteritis virus. Proceedings of the fifth international conference on equine infectious diseases, Lexington, 1987. University Press of Kentucky, Lexington, pp 3–12
Murphy TW, McCollum WH, Timoney PJ, Klingeborn BW, Hyllseth B, Golnik W, Erasmus B (1992) Genomic variability among globally distributed isolates of equine arteritis virus. Vet Microbiol 32: 101–115
Plagemann PGW, Moennig V (1992) Lactate dehydrogenase-elevating virus, equine arteritis virus, and simian hemorrhagic fever virus: a new group of positive-strand RNA viruses. Adv Virus Res 41: 99–192
Porterfield JS, Casals J, Chumakov MP, Gaidamovich SY, Hannoun C, Holmes IH, Horzinek MC, Mussgay M, Oker-Blom N, Russel PK, Trent DW (1978) Togaviridae. Intervirology 9: 129–148
Sugita S, Kondo T, Sekiguchi K, Yamaguchi S, Kamada M, Nerome K, Fukunaga Y (1994) Molecular evolution of equine arteritis virus. Proceedings of the seventh international conference on infectious diseases, Tokyo, 1994. R&W Publications, Newmarket, pp 39–43
Westaway EG, Brinton MA, Gaidamovich SY, Horzinek MC, Igarashi A, Kääriäinen L, Lvov DK, Porterfield JS, Russell PK, Trent DW (1984) Togaviridae. Intervirology 24: 125–139
Yamaguchi S, Kanno T, Inoue T, Sugita S, Fukunaga Y (1994) Sequence analysis of modified Bucyrus strain of equine arteritis virus. Proceedings of the seventh international conference on equine infectious diseases, Tokyo, 1994. R&W Publications, Newmarket, p 339
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sekiguchi, K., Sugita, S., Fukunaga, Y. et al. Detection of equine arteritis virus (EAV) by polymerase chain reaction (PCR) and differentiation of EAV strains by restriction enzyme analysis of PCR products. Archives of Virology 140, 1483–1491 (1995). https://doi.org/10.1007/BF01322675
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01322675